Kestra Medical Technologies (NASDAQ:KMTS) Stock Breaks Below Fifty Day Moving Average – Should You Sell?

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS – Get Free Report)’s share price crossed below its fifty day moving average during trading on Thursday. The stock has a fifty day moving average of $27.63 and traded as low as $26.34. Kestra Medical Technologies shares last traded at $26.63, with a volume of 382,493 shares changing hands.

Analysts Set New Price Targets

A number of analysts recently commented on KMTS shares. Royal Bank Of Canada set a $30.00 target price on shares of Kestra Medical Technologies in a research note on Tuesday, September 15th. Piper Sandler restated an “overweight” rating on shares of Kestra Medical Technologies in a research note on Tuesday, September 15th. Wall Street Zen cut shares of Kestra Medical Technologies from a “hold” rating to a “sell” rating in a report on Sunday, November 8th. JPMorgan Chase & Co. assumed coverage on shares of Kestra Medical Technologies in a report on Monday, August 10th. They issued an “overweight” rating and a $30.00 price target for the company. Finally, BTIG Research reiterated a “buy” rating and set a $32.00 price objective on shares of Kestra Medical Technologies in a research note on Tuesday, September 15th. Five equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Kestra Medical Technologies currently has a consensus rating of “Moderate Buy” and a consensus target price of $29.00.

Get Our Latest Stock Report on KMTS

Kestra Medical Technologies Stock Performance

The company has a quick ratio of 4.69, a current ratio of 4.69 and a debt-to-equity ratio of 0.33. The stock has a market capitalization of $1.50 billion, a PE ratio of -9.41 and a beta of 0.45. The firm has a 50 day moving average price of $27.68 and a 200-day moving average price of $24.17.

Kestra Medical Technologies (NASDAQ:KMTS – Get Free Report) last issued its earnings results on Monday, September 14th. The company reported ($0.75) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.61) by ($0.14). Kestra Medical Technologies had a negative return on equity of 63.83% and a negative net margin of 140.43%. The business had revenue of $30.97 million for the quarter. Research analysts expect that Kestra Medical Technologies, Ltd. will post -2.45 EPS for the current fiscal year.

Insider Buying and Selling at Kestra Medical Technologies

In other news, insider Brian Webster sold 15,000 shares of the business’s stock in a transaction dated Tuesday, October 20th. The stock was sold at an average price of $29.56, for a total value of $443,400.00. Following the completion of the transaction, the insider owned 445,215 shares of the company’s stock, valued at $13,160,555.40. The trade was a 3.26% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Traci Umberger sold 100,000 shares of the company’s stock in a transaction dated Wednesday, October 21st. The stock was sold at an average price of $27.18, for a total value of $2,718,000.00. Following the completion of the sale, the insider owned 195,825 shares in the company, valued at $5,322,523.50. The trade was a 33.80% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 251,456 shares of company stock worth $7,173,746. Insiders own 5.30% of the company’s stock.

Institutional Investors Weigh In On Kestra Medical Technologies

A number of hedge funds and other institutional investors have recently made changes to their positions in KMTS. Sterling Capital Management LLC lifted its stake in shares of Kestra Medical Technologies by 834.0% in the 3rd quarter. Sterling Capital Management LLC now owns 878 shares of the company’s stock valued at $25,000 after purchasing an additional 784 shares during the period. Global Retirement Partners LLC grew its position in Kestra Medical Technologies by 56,300.0% during the third quarter. Global Retirement Partners LLC now owns 1,692 shares of the company’s stock valued at $48,000 after buying an additional 1,689 shares during the period. The Manufacturers Life Insurance Company grew its position in Kestra Medical Technologies by 6.6% during the first quarter. The Manufacturers Life Insurance Company now owns 92,515 shares of the company’s stock valued at $1,844,000 after buying an additional 5,731 shares during the period. California State Teachers Retirement System increased its holdings in Kestra Medical Technologies by 39.2% in the first quarter. California State Teachers Retirement System now owns 27,835 shares of the company’s stock valued at $555,000 after buying an additional 7,844 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. purchased a new position in Kestra Medical Technologies in the third quarter valued at $353,000.

About Kestra Medical Technologies

(Get Free Report)

Kestra Medical Technologies is a medical technology company focused on wearable solutions for people at risk of sudden cardiac arrest. Its products combine cardiac monitoring, treatment technology and digital services intended to support patients and their care teams. The company’s flagship product, the ASSURE wearable cardioverter defibrillator, continuously monitors a patient’s heart rhythm and can deliver a treatment shock if it detects a life-threatening arrhythmia. The system also provides alerts and supports remote sharing of patient data with clinicians.

Recommended Stories

Receive News & Ratings for Kestra Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kestra Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.